The global cefetamet pivoxil tablets market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The market growth is majorly attributed owing to the rising application of these tablets in treating various medical conditions. The medicine is found to be effective in the treatment of sinusitis, ear, nose and/or throat infections, pharyngo-tonsillitis, otitis media, lower respiratory tract infections, acute bacterial exacerbation of chronic bronchitis, tracheo-bronchitis, pneumonia, and urinary tract infections, among numerous other medical conditions. 

Thus, the growing target patient population is anticipated to surge the market growth. For instance, as per the World Health Organization (WHO) pneumonia is the single largest infectious cause of mortalities in children all around the globe. The stats show that the disease killed 740,180 children under the age of 5 in 2019, accounting for 14% of all mortalities of children under 5 years old, however, 22% of all mortalities in children aged 1 to 5. This, in turn, is driving the demand for Cefetamet Pivoxil tablets for the treatment of pneumonia. 

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment Covered- 

o By Application 

o By Type

• Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

    • Competitive Landscape:  Merck KGaA, and Zydus Cadila Healthcare Ltd., among others.

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How are players addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Cefetamet Pivoxil Tablets Market Report by Segment

By Application 

    • Ear, Nose, and/or Throat Infection

    • Otitis Media

    • Sinusitis

    • Pharyngo-Tonsillitis

    • Lower Respiratory Tract

    • Acute Bacterial Exacerbation of Chronic Bronchitis

    • Tracheo-Bronchitis

    • Pneumonia

    • Urinary Tract Infections

    • Others

By Type

    • 6 Months-3 Years

    • 3-9 Years

    • 9-12 Years

    • Over 12 Years

Global Cefetamet Pivoxil Tablets Market by Region

North America       

    • US

    • Canada

Europe

    • Germany

    • UK

    • France

    • Spain

    • Italy

    • Rest of Europe

Asia-Pacific    

    • China

    • Japan

    • India

    • Rest of Asia-Pacific

Rest of the World

    • Latin America

    • Middle East and Africa